Literature DB >> 20859408

Editorial: gene expression profile assays as an aid in treatment decision making in early-stage breast cancer.

Gary H Lyman.   

Abstract

Entities:  

Year:  2007        PMID： 20859408      PMCID： PMC2793817          DOI： 10.1200/JOP.0741502

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  14 in total

Review 1.  Methodological challenges in the evaluation of prognostic factors in breast cancer.

Authors:  D G Altman; G H Lyman
Journal:  Breast Cancer Res Treat       Date:  1998       Impact factor: 4.872

2.  Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.

Authors:  John Hornberger; Leon E Cosler; Gary H Lyman
Journal:  Am J Manag Care       Date:  2005-05       Impact factor: 2.229

3.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Authors:  Soonmyung Paik; Gong Tang; Steven Shak; Chungyeul Kim; Joffre Baker; Wanseop Kim; Maureen Cronin; Frederick L Baehner; Drew Watson; John Bryant; Joseph P Costantino; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-05-23       Impact factor: 44.544

4.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

5.  Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer.

Authors:  Ruth Oratz; Dev Paul; Allen L Cohn; Scot M Sedlacek
Journal:  J Oncol Pract       Date:  2007-07       Impact factor: 3.840

6.  Quality of life after adjuvant chemotherapy for breast cancer.

Authors:  J A Broeckel; P B Jacobsen; L Balducci; J Horton; G H Lyman
Journal:  Breast Cancer Res Treat       Date:  2000-07       Impact factor: 4.872

7.  Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.

Authors:  Gary H Lyman; Leon E Cosler; Nicole M Kuderer; John Hornberger
Journal:  Cancer       Date:  2007-03-15       Impact factor: 6.860

8.  Gene expression profile assays as predictors of recurrence-free survival in early-stage breast cancer: a metaanalysis.

Authors:  Gary H Lyman; Nicole M Kuderer
Journal:  Clin Breast Cancer       Date:  2006-12       Impact factor: 3.225

9.  Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.

Authors:  Bernard Fisher; Jong-Hyeon Jeong; John Bryant; Stewart Anderson; James Dignam; Edwin R Fisher; Norman Wolmark
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

10.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.